\-\ Texto\\:\\ \ \(0\)\
\-\ neurologic\\ exam\\:\\ slurred\\ speech\\.\\ oriented\\ only\\ to\\ year\\ and\\ name\\.\\ poor\\ concentration\\.\\ bilateral\\ nystagmus\\.\\ positive\\ for\\ weakness\\ 2\\/5\\ in\\ proximal\\ muscles\\ of\\ upper\\ and\\ lower\\ extremity\\.\\ decreased\\ vibratory\\ sensation\\ in\\ feet\\ and\\ ankles\\.\\ bilateral\\ upgoing\\ toes\\.\\ unable\\ to\\ stand\\ on\\ own\\.\\ \ \(0\)\
\-\ labs\\:\\ sodium\\ on\\ admission\\ was\\ 171\\ meq\\/l\\ with\\ glucose\\ 105mg\\/dl\\.\\ 6\\ hours\\ later\\ na\\+\\+\\ \\=169meq\\/l\\;\\ 24\\ hours\\ later\\ \\ na\\+\\+\\ \\=164\\ meq\\/l\\;\\ 48\\ hours\\ later\\ \\ na\\+\\+\\ \\=138\\ meq\\/l\\.\ \(0\)\
\-\ sodium\\ has\\ been\\ maintained\\ at\\ normal\\ levels\\.\\ patient\\ is\\ working\\ with\\ physical\\ therapy\ \(0\)\
\-\ central\\ pontine\\ mri\\ signal\\ abnormalities\\ with\\ sparing\\ of\\ the\\ peripheral\\ pontine\\ fibers\\.\\ t1\\ signal\\ hypointense\\,\\ t2\\ \\ and\\ flair\\ signal\\ hyperintense\\.\\ mild\\ diffusion\\ restriction\\ with\\ corresponding\\ low\\ adc\\.\ \(0\)\
\-\ osmotic\\ myelinolysis\\,\\ central\\ pontine\\ myelinolysis\ \(0\)\
\-\ pontine\\ ischemia\\,\\ demyelinating\\ disease\\ or\\ metabolic\\ disease\\.\ \(0\)\
\-\ 50\\ y\\.o\\.\\ man\\ with\\ etoh\\ abuse\\ presenting\\ with\\ intoxication\\ and\\ hypernatremia\\.\\ complains\\ of\\ progressive\\ upper\\ and\\ lower\\ extremity\\ weakness\\ on\\ day\\ 5\\ of\\ admission\ \(0\)\
\-\ formerly\\ known\\ as\\ central\\ pontine\\ myelinolysis\\,\\ osmotic\\ demyelination\\ syndrome\\ is\\ classically\\ seen\\ in\\ association\\ of\\ rapid\\ correction\\ of\\ hyponatremia\\ but\\ can\\ occasionally\\ be\\ seen\\ on\\ cases\\ of\\ rapid\\ correction\\ of\\ hypernatremia\\,\\ as\\ seen\\ in\\ this\\ case\\.\\ chronic\\ hypernatremia\\ should\\ be\\ corrected\\ slowly\\ due\\ to\\ the\\ risk\\ of\\ brain\\ edema\\ which\\ may\\ lead\\ to\\ brain\\ herniation\\,\\ permanent\\ neurologic\\ deficits\\ and\\ lysis\\ of\\ myelin\\.\\ in\\ this\\ case\\,\\ the\\ time\\ course\\ of\\ the\\ hypernatremia\\ was\\ unknown\\.\\ typical\\ presentation\\ is\\ usually\\ neurologic\\ deterioration\\ 48\\-72\\ hours\\ after\\ the\\ sodium\\ level\\ has\\ been\\ corrected\\.\\ pseudobulbar\\ palsy\\ and\\ spastic\\ quadriplegia\\ are\\ two\\ of\\ the\\ physical\\ findings\\ often\\ associated\\ with\\ the\\ syndrome\\.\\ \\ \\ there\\ is\\ a\\ large\\ spectrum\\ of\\ outcomes\\ ranging\\ from\\ complete\\ recovery\\ to\\ a\\ total\\ \\‚\\Ä\\úlocked\\ in\\‚\\Ä\\ù\\ state\\ which\\ may\\ progress\\ to\\ coma\\ and\\ even\\ death\\.\\ \ \(0\)\
\-\ references\\:\ \(0\)\
\-\ 1\\.\\	diagnostic\\ imaging\\:\\ brain\\.\\ osborn\\,\\ et\\ al\\.\\ 2004\\.\\ \ \(0\)\
\-\ 2\\.\\	central\\ pontine\\ myelinolysis\\.\\ luzzio\\,\\ c\\.\\ \\ e\\-medicine\\ online\\.\\ http\\:\\/\\/www\\.emedicine\\.com\\/neuro\\/topic50\\.htm\ \(0\)\
\-\ 3\\.\\	hypernatremia\\.\\ pham\\,\\ t\\.\\ e\\-medicine\\ online\\.\\ http\\:\\/\\/www\\.emedicine\\.com\\/med\\/topic1089\\.htm\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hypernatremia\\:\\ 0\\.1160338749058079\ \(0\)\
\-\ pontine\\:\\ 0\\.09976776257850012\ \(0\)\
\-\ myelinolysis\\:\\ 0\\.08819321297483872\ \(0\)\
\-\ na\\+\\+\\:\\ 0\\.07556158649114142\ \(0\)\
\-\ meq\\/l\\:\\ 0\\.06962032494348475\ \(0\)\
\-\ e\\-medicine\\:\\ 0\\.05037439099409428\ \(0\)\
\-\ sodium\\:\\ 0\\.04868592178317727\ \(0\)\
\-\ osmotic\\:\\ 0\\.041177602923042275\ \(0\)\
\-\ online\\:\\ 0\\.038491867898780924\ \(0\)\
\-\ hours\\:\\ 0\\.038402254955529104\ \(0\)\
\-\ corrected\\:\\ 0\\.03385798094897333\ \(0\)\
\-\ central\\:\\ 0\\.03213292979268525\ \(0\)\
\-\ neurologic\\:\\ 0\\.030587094444051534\ \(0\)\
\-\ correction\\:\\ 0\\.02790681594995527\ \(0\)\
\-\ later\\:\\ 0\\.026446445494225063\ \(0\)\
\-\ 105mg\\/dl\\:\\ 0\\.02518719549704714\ \(0\)\
\-\ \\=169meq\\/l\\:\\ 0\\.02518719549704714\ \(0\)\
\-\ \\=164\\:\\ 0\\.02518719549704714\ \(0\)\
\-\ \\=138\\:\\ 0\\.02518719549704714\ \(0\)\
\-\ pseudobulbar\\:\\ 0\\.02518719549704714\ \(0\)\
\-\ luzzio\\:\\ 0\\.02518719549704714\ \(0\)\
\-\ \\/\\/www\\.emedicine\\.com\\/neuro\\/topic50\\.htm\\:\\ 0\\.02518719549704714\ \(0\)\
\-\ \\/\\/www\\.emedicine\\.com\\/med\\/topic1089\\.htm\\:\\ 0\\.02518719549704714\ \(0\)\
\-\ rapid\\:\\ 0\\.024661192877921335\ \(0\)\
\-\ 48\\-72\\:\\ 0\\.02320677498116158\ \(0\)\
\-\ pham\\:\\ 0\\.02320677498116158\ \(0\)\
\-\ vibratory\\:\\ 0\\.02204830324370968\ \(0\)\
\-\ upgoing\\:\\ 0\\.02204830324370968\ \(0\)\
\-\ 171\\:\\ 0\\.02204830324370968\ \(0\)\
\-\ brain\\:\\ 0\\.022040155914023675\ \(0\)\
\-\ admission\\:\\ 0\\.02151807095266835\ \(0\)\
\-\ formerly\\:\\ 0\\.020067882727824123\ \(0\)\
\-\ hyponatremia\\:\\ 0\\.019627452214031955\ \(0\)\
\-\ \\:\\:\\ 0\\.019376139702697116\ \(0\)\
\-\ signal\\:\\ 0\\.01931206568805239\ \(0\)\
\-\ spastic\\:\\ 0\\.019245933949390462\ \(0\)\
\-\ quadriplegia\\:\\ 0\\.019245933949390462\ \(0\)\
\-\ myelin\\:\\ 0\\.018909410990372223\ \(0\)\
\-\ osborn\\:\\ 0\\.018909410990372223\ \(0\)\
\-\ locked\\:\\ 0\\.018608380945635578\ \(0\)\
\-\ http\\:\\ 0\\.01849022055988729\ \(0\)\
\-\ intoxication\\:\\ 0\\.01833606614619465\ \(0\)\
\-\ weakness\\:\\ 0\\.018134922017305054\ \(0\)\
\-\ 2\\/5\\:\\ 0\\.018087462211938566\ \(0\)\
\-\ lysis\\:\\ 0\\.017858768761442746\ \(0\)\
\-\ extremity\\:\\ 0\\.017858051255099646\ \(0\)\
\-\ slurred\\:\\ 0\\.0176470316981464\ \(0\)\
\-\ name\\:\\ 0\\.016928990474486667\ \(0\)\
\-\ t\\.\\:\\ 0\\.016928990474486667\ \(0\)\
\-\ concentration\\:\\ 0\\.01677451269942874\ \(0\)\
\-\ deterioration\\:\\ 0\\.01677451269942874\ \(0\)\
\-\ outcomes\\:\\ 0\\.01677451269942874\ \(0\)\
\-\ ranging\\:\\ 0\\.01677451269942874\ \(0\)\
\-\ ankles\\:\\ 0\\.01662796042975002\ \(0\)\
\-\ stand\\:\\ 0\\.01662796042975002\ \(0\)\
\-\ restriction\\:\\ 0\\.0164885599606945\ \(0\)\
\-\ demyelination\\:\\ 0\\.016228640594392423\ \(0\)\
\-\ etoh\\:\\ 0\\.015990407425995137\ \(0\)\
\-\ own\\:\\ 0\\.01566661118226084\ \(0\)\
\-\ permanent\\:\\ 0\\.01566661118226084\ \(0\)\
\-\ working\\:\\ 0\\.015566350268514353\ \(0\)\
\-\ nystagmus\\:\\ 0\\.015375803484232434\ \(0\)\
\-\ coma\\:\\ 0\\.015375803484232434\ \(0\)\
\-\ maintained\\:\\ 0\\.015285092917619347\ \(0\)\
\-\ demyelinating\\:\\ 0\\.015111879712429534\ \(0\)\
\-\ adc\\:\\ 0\\.014576989592177687\ \(0\)\
\-\ toes\\:\\ 0\\.014508139444808941\ \(0\)\
\-\ sparing\\:\\ 0\\.014508139444808941\ \(0\)\
\-\ seen\\:\\ 0\\.014473950986294488\ \(0\)\
\-\ classically\\:\\ 0\\.014248220078506867\ \(0\)\
\-\ abuse\\:\\ 0\\.014186773777875543\ \(0\)\
\-\ spectrum\\:\\ 0\\.014126621180167451\ \(0\)\
\-\ c\\.\\:\\ 0\\.014126621180167451\ \(0\)\
\-\ speech\\:\\ 0\\.014067708931016776\ \(0\)\
\-\ syndrome\\:\\ 0\\.013965180438483665\ \(0\)\
\-\ state\\:\\ 0\\.01379009822114921\ \(0\)\
\-\ progress\\:\\ 0\\.01379009822114921\ \(0\)\
\-\ fibers\\:\\ 0\\.013737672110668649\ \(0\)\
\-\ palsy\\:\\ 0\\.013537088514459367\ \(0\)\
\-\ recovery\\:\\ 0\\.013304672401733789\ \(0\)\
\-\ been\\:\\ 0\\.013284542225508521\ \(0\)\
\-\ slowly\\:\\ 0\\.013260374725916745\ \(0\)\
\-\ death\\:\\ 0\\.01317378801307295\ \(0\)\
\-\ 2004\\:\\ 0\\.013131459196543975\ \(0\)\
\-\ glucose\\:\\ 0\\.013048637662620398\ \(0\)\
\-\ occasionally\\:\\ 0\\.01285151517265768\ \(0\)\
\-\ feet\\:\\ 0\\.012493906192789091\ \(0\)\
\-\ corresponding\\:\\ 0\\.012427458015176899\ \(0\)\
\-\ metabolic\\:\\ 0\\.012058281639519738\ \(0\)\
\-\ physical\\:\\ 0\\.01198003011189279\ \(0\)\
\-\ oriented\\:\\ 0\\.011972987459092076\ \(0\)\
\-\ 48\\:\\ 0\\.011945112673533893\ \(0\)\
\-\ association\\:\\ 0\\.01186308379958409\ \(0\)\
\-\ bilateral\\:\\ 0\\.011850387024653965\ \(0\)\
\-\ upper\\:\\ 0\\.011783317173535533\ \(0\)\
\-\ lead\\:\\ 0\\.011705770150489724\ \(0\)\
\-\ hypointense\\:\\ 0\\.011580984254767834\ \(0\)\
\-\ \\;\\:\\ 0\\.01157383536258625\ \(0\)\
\-\ ischemia\\:\\ 0\\.011346660964308307\ \(0\)\
\-\ complains\\:\\ 0\\.011346660964308307\ \(0\)\
\-\ unable\\:\\ 0\\.011279954210031187\ \(0\)\
\-\ sensation\\:\\ 0\\.011214769416413556\ \(0\)\
\-\ flair\\:\\ 0\\.011193367497187391\ \(0\)\
\-\ deficits\\:\\ 0\\.011172124701508768\ \(0\)\
\-\ muscles\\:\\ 0\\.011151038680658419\ \(0\)\
\-\ poor\\:\\ 0\\.010987728926829993\ \(0\)\
\-\ lower\\:\\ 0\\.010982068967793501\ \(0\)\
\-\ diffusion\\:\\ 0\\.01092881667767932\ \(0\)\
\-\ herniation\\:\\ 0\\.01087109465677212\ \(0\)\
\-\ even\\:\\ 0\\.01087109465677212\ \(0\)\
\-\ may\\:\\ 0\\.010710447822274993\ \(0\)\
\-\ case\\:\\ 0\\.010682882473527262\ \(0\)\
\-\ total\\:\\ 0\\.010513485676903533\ \(0\)\
\-\ al\\:\\ 0\\.010350175923075109\ \(0\)\
\-\ references\\:\\ 0\\.01015093781446175\ \(0\)\
\-\ hyperintense\\:\\ 0\\.01013617218543763\ \(0\)\
\-\ levels\\:\\ 0\\.01007786112363418\ \(0\)\
\-\ et\\:\\ 0\\.00999256694320652\ \(0\)\
\-\ presenting\\:\\ 0\\.009950856087717511\ \(0\)\
\-\ typical\\:\\ 0\\.009789847697571422\ \(0\)\
\-\ diagnostic\\:\\ 0\\.009674779414320163\ \(0\)\
\-\ progressive\\:\\ 0\\.009649826042980866\ \(0\)\
\-\ unknown\\:\\ 0\\.009528227144641448\ \(0\)\
\-\ 24\\:\\ 0\\.009492734230359855\ \(0\)\
\-\ 50\\:\\ 0\\.009288565761839443\ \(0\)\
\-\ course\\:\\ 0\\.009212946981301833\ \(0\)\
\-\ has\\:\\ 0\\.009169714117110159\ \(0\)\
\-\ \\‚\\Ä\\ú\\:\\ 0\\.0091185740507976\ \(0\)\
\-\ which\\:\\ 0\\.009115111927100279\ \(0\)\
\-\ \\‚\\Ä\\ù\\:\\ 0\\.009067461008652527\ \(0\)\
\-\ abnormalities\\:\\ 0\\.008967898919137761\ \(0\)\
\-\ risk\\:\\ 0\\.008843447563883104\ \(0\)\
\-\ peripheral\\:\\ 0\\.00883409520575462\ \(0\)\
\-\ complete\\:\\ 0\\.008592502668531584\ \(0\)\
\-\ labs\\:\\ 0\\.008491354305528966\ \(0\)\
\-\ presentation\\:\\ 0\\.00840971609854595\ \(0\)\
\-\ 3\\.\\:\\ 0\\.008353926320402077\ \(0\)\
\-\ on\\:\\ 0\\.008273040141319177\ \(0\)\
\-\ cases\\:\\ 0\\.008133745325660378\ \(0\)\
\-\ disease\\:\\ 0\\.007981357378375452\ \(0\)\
\-\ positive\\:\\ 0\\.00792253025795462\ \(0\)\
\-\ often\\:\\ 0\\.007789924424341864\ \(0\)\
\-\ should\\:\\ 0\\.007783452976825143\ \(0\)\
\-\ 2\\.\\:\\ 0\\.007764126119429309\ \(0\)\
\-\ day\\:\\ 0\\.0077513137981512275\ \(0\)\
\-\ t1\\:\\ 0\\.007738558674926411\ \(0\)\
\-\ \\,\\:\\ 0\\.007734573300493925\ \(0\)\
\-\ known\\:\\ 0\\.007725860241325199\ \(0\)\
\-\ 1\\.\\:\\ 0\\.007626254760850288\ \(0\)\
\-\ be\\:\\ 0\\.007530038419108167\ \(0\)\
\-\ usually\\:\\ 0\\.007414080725333597\ \(0\)\
\-\ as\\:\\ 0\\.007386157176537873\ \(0\)\
\-\ only\\:\\ 0\\.007341176167099816\ \(0\)\
\-\ proximal\\:\\ 0\\.007330123376305757\ \(0\)\
\-\ to\\:\\ 0\\.0073211675733083365\ \(0\)\
\-\ 6\\:\\ 0\\.007291771889642498\ \(0\)\
\-\ decreased\\:\\ 0\\.007259304007784456\ \(0\)\
\-\ in\\:\\ 0\\.0072239525166900844\ \(0\)\
\-\ 5\\:\\ 0\\.007143315492697609\ \(0\)\
\-\ y\\.o\\:\\ 0\\.0070467983788191435\ \(0\)\
\-\ level\\:\\ 0\\.0070368257932769485\ \(0\)\
\-\ two\\:\\ 0\\.006992374964617159\ \(0\)\
\-\ t2\\:\\ 0\\.006910253625001006\ \(0\)\
\-\ edema\\:\\ 0\\.0069054956840894025\ \(0\)\
\-\ time\\:\\ 0\\.006896003506398036\ \(0\)\
\-\ chronic\\:\\ 0\\.006877113236877143\ \(0\)\
\-\ low\\:\\ 0\\.006789051579618285\ \(0\)\
\-\ therapy\\:\\ 0\\.006527545132116037\ \(0\)\
\-\ due\\:\\ 0\\.006515077579865256\ \(0\)\
\-\ mild\\:\\ 0\\.006429295582660391\ \(0\)\
\-\ is\\:\\ 0\\.0064261803243968645\ \(0\)\
\-\ man\\:\\ 0\\.00577409098025714\ \(0\)\
\-\ associated\\:\\ 0\\.005761321605450577\ \(0\)\
\-\ imaging\\:\\ 0\\.005720210927016007\ \(0\)\
\-\ was\\:\\ 0\\.005647300126935353\ \(0\)\
\-\ mri\\:\\ 0\\.005609359585470343\ \(0\)\
\-\ can\\:\\ 0\\.0055377781499116275\ \(0\)\
\-\ this\\:\\ 0\\.0054922126475093315\ \(0\)\
\-\ exam\\:\\ 0\\.005363525542712966\ \(0\)\
\-\ large\\:\\ 0\\.005338692662374514\ \(0\)\
\-\ but\\:\\ 0\\.00520715228866725\ \(0\)\
\-\ findings\\:\\ 0\\.005196676959399885\ \(0\)\
\-\ after\\:\\ 0\\.005051432007454864\ \(0\)\
\-\ and\\:\\ 0\\.00462880300454276\ \(0\)\
\-\ of\\:\\ 0\\.00432728402963957\ \(0\)\
\-\ normal\\:\\ 0\\.0038274641559974316\ \(0\)\
\-\ there\\:\\ 0\\.003633473018471396\ \(0\)\
\-\ from\\:\\ 0\\.0036183877518691783\ \(0\)\
\-\ are\\:\\ 0\\.0033282110643702905\ \(0\)\
\-\ at\\:\\ 0\\.0033078947223760943\ \(0\)\
\-\ \\.\\:\\ 0\\.003042817379772538\ \(0\)\
\-\ or\\:\\ 0\\.0028614935684677357\ \(0\)\
\-\ the\\:\\ 0\\.002764985694072516\ \(0\)\
\-\ year\\:\\ 0\\.0027317293407797564\ \(0\)\
\-\ patient\\:\\ 0\\.0024474055169039655\ \(0\)\
\-\ with\\:\\ 0\\.002340083521797795\ \(0\)\
\-\ a\\:\\ 0\\.0022662845818205786\ \(0\)\
\-\ for\\:\\ 0\\.0020831661389791862\ \(0\)\
